These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 3941271

  • 1. In vivo or in vitro selection for resistance to natural cytotoxic cell lysis selects for variants with increased tumorigenicity.
    Patek PQ, Lin Y, Collins JL, Cohn M.
    J Immunol; 1986 Jan; 136(2):741-5. PubMed ID: 3941271
    [Abstract] [Full Text] [Related]

  • 2. In vitro selection of a cell line for resistance to lysis by tumor necrosis factor-alpha selects for reduced tumorigenicity.
    Patek PQ, Lin Y.
    J Immunol; 1991 May 15; 146(10):3457-61. PubMed ID: 2026874
    [Abstract] [Full Text] [Related]

  • 3. Differential tumorigenicity of 3T3 cells transformed in vitro with polyoma virus and in vivo selection for high tumorigenicity.
    Halachmi E, Witz IP.
    Cancer Res; 1989 May 01; 49(9):2383-9. PubMed ID: 2539901
    [Abstract] [Full Text] [Related]

  • 4. An analysis of the sensitivity of somatic cell hybrids to natural killer cell- and natural cytotoxic cell-mediated lysis.
    Lin Y, Collins JL, Patek PQ, Cohn M.
    J Immunol; 1983 Sep 01; 131(3):1154-9. PubMed ID: 6604090
    [Abstract] [Full Text] [Related]

  • 5. Susceptibility of Adenovirus 2-transformed rat cell lines to natural killer (NK) cells: direct correlation between NK resistance and in vivo tumorigenesis.
    Sheil JM, Gallimore PH, Zimmer SG, Sopori ML.
    J Immunol; 1984 Mar 01; 132(3):1578-82. PubMed ID: 6319497
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Natural cytotoxic cells and tumor necrosis factor activate similar lytic mechanisms.
    Patek PQ, Lin Y, Collins JL.
    J Immunol; 1987 Mar 01; 138(5):1641-6. PubMed ID: 3805728
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Immunological and morphological properties of in vitro transformed fibroblasts. III. Recognition by macrophages and activated lymphocytes of mouse and rat cells of various degrees of tumorigenicity].
    Lavrovskiĭ VA, Iurchenko IuA, Guvakova MA.
    Tsitologiia; 1987 May 01; 29(5):589-95. PubMed ID: 3617224
    [Abstract] [Full Text] [Related]

  • 17. Evidence that cytotoxic T cells and natural cytotoxic cells use different lytic mechanisms to lyse the same targets.
    Patek PQ, Collins JL, Cohn M.
    Eur J Immunol; 1983 May 01; 13(5):433-6. PubMed ID: 6189729
    [Abstract] [Full Text] [Related]

  • 18. Solid tumor-derived target cell susceptibility to macrophages and natural killer/natural cytotoxic cells in the rat.
    Zöller M, Matzku S.
    Immunobiology; 1983 May 01; 164(5):349-60. PubMed ID: 6603412
    [Abstract] [Full Text] [Related]

  • 19. The tumorigenicity of IL-2 gene-transfected murine M-3D melanoma cells is determined by the magnitude and quality of the host defense reaction: NK cells play a major role.
    Schneeberger A, Koszik F, Schmidt W, Kutil R, Stingl G.
    J Immunol; 1999 Jun 01; 162(11):6650-7. PubMed ID: 10352282
    [Abstract] [Full Text] [Related]

  • 20. In vitro and in vivo characteristics of human squamous cell carcinoma of the head and neck cells engineered to secrete interleukin-2.
    Nagashima S, Reichert TE, Kashii Y, Suminami Y, Chikamatsu K, Whiteside TL.
    Cancer Gene Ther; 1997 Jun 01; 4(6):366-76. PubMed ID: 9408607
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.